Too Fast or Not Too Fast:
The FDA’s Approval of Merck’s HPV Vaccine Gardasil
authors: Lucija Tomljenovic and Christopher A. Shaw
Tables in this study show, for example, that the Gardasil vaccine accounts for over 60% of all vaccine-related death reports;The Gardasil vaccine accounts for over 80% of vaccine-related permanent disabilities reports. You can contact the authors to read this study: Lucija Tomljenovic email@example.com
Excerpt: “Merck’s HPV vaccine Gardasil failed (and continues to fail) to meet a single one of the four criteria required by the FDA for Fast Track approval. In spite of this, Gardasil continues to be promoted as if it already had post-phase 4 confirmatory trial approval and proven efficacy
against cervical cancer…”
FDA and CDC rely exclusively on data provided by the manufacturer. Disregarding the abundance of adverse events reported to the Vaccine Adverse Events Report System (VAERS), independent research studies, outcries from doctors who have the courage to speak out and heartbreaking personal stories – the official sound bite from the FDA and CDC is that Gardasil is safe and effective, and its benefits continue to outweigh its risks.
Excerpt: “Any federal agency responsible for assuring drug safety should not exclusively rely on data provided by the drug manufacturer, as unreliable research (i.e., use of an reactive and potentially toxic placebo) cannot be used to reliably evaluate the safety of any drug”.